PDL BIOPHARMA INC's ticker is PDLI and the CUSIP is 69329Y104. A total of 203 filers reported holding PDL BIOPHARMA INC in Q2 2015. The put-call ratio across all filers is 0.19 and the average weighting 0.0%.
Quarter-by-quarter ownership
Value | Shares | Weighting | ||||
---|---|---|---|---|---|---|
Q1 2018 | $1,000 | -100.0% | 255 | -100.0% | 0.00% | -100.0% |
Q4 2015 | $3,141,000 | -39.5% | 887,214 | -14.0% | 0.53% | -32.1% |
Q3 2015 | $5,189,000 | -22.2% | 1,031,540 | -0.6% | 0.78% | -18.8% |
Q2 2015 | $6,672,000 | -15.3% | 1,037,600 | -7.3% | 0.97% | -5.0% |
Q1 2015 | $7,878,000 | -7.8% | 1,119,794 | +1.1% | 1.02% | -11.0% |
Q4 2014 | $8,540,000 | -11.9% | 1,107,698 | -14.7% | 1.14% | -10.8% |
Q3 2014 | $9,699,000 | – | 1,298,459 | – | 1.28% | – |
Download |
Other shareholders
Name | Shares | Value | Weighting ↓ |
---|---|---|---|
ARMISTICE CAPITAL, LLC | 2,632,000 | $8,817,000 | 2.83% |
AMERICAFIRST CAPITAL MANAGEMENT, LLC | 551,804 | $1,848,543,000 | 1.54% |
Nine Chapters Capital Management LLC | 24,300 | $81,000 | 0.57% |
GREAT POINT PARTNERS LLC | 645,000 | $2,161,000 | 0.55% |
Virtus ETF Advisers LLC | 198,901 | $666,000 | 0.32% |
GSA CAPITAL PARTNERS LLP | 1,521,224 | $5,096,000 | 0.27% |
Amici Capital, LLC | 200,000 | $670,000 | 0.18% |
Acrospire Investment Management LLC | 70,622 | $237,000 | 0.16% |
RBF Capital, LLC | 273,976 | $918,000 | 0.16% |
SECOR Capital Advisors, LP | 383,971 | $1,286,000 | 0.14% |